Haemagglutinin-strain A(H1N1)
- Generic Name
- Haemagglutinin-strain A(H1N1)
- Brand Names
- Afluria Tetra, Agriflu, FluLaval Tetra, Fluad, Fluad Pediatric, Fluviral, Fluzone High-Dose Quadrivalent, Fluzone Quadrivalent, Influvac Tetra
- Drug Type
- Biotech
High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant
Phase 2
Completed
- Conditions
- Hematopoietic Cell Transplantation RecipientMalignant NeoplasmInfluenza
- Interventions
- Other: Laboratory Biomarker Analysis
- First Posted Date
- 2016-08-09
- Last Posted Date
- 2024-10-22
- Lead Sponsor
- Vanderbilt-Ingram Cancer Center
- Target Recruit Count
- 170
- Registration Number
- NCT02860039
- Locations
- 🇺🇸
Nationwide Children's Hospital, Columbus, Ohio, United States
🇺🇸Texas Children's Hospital, Houston, Texas, United States
🇺🇸UCSF Children's Hospital, San Francisco, California, United States
Rapid Evaluation of Seasonal Influenza Vaccine
- First Posted Date
- 2009-08-26
- Last Posted Date
- 2009-10-23
- Lead Sponsor
- University of British Columbia
- Target Recruit Count
- 300
- Registration Number
- NCT00966342
- Locations
- 🇨🇦
Mt Sinai Hospital, Toronto, Ontario, Canada
🇨🇦KFLA Public Health Department, Kingston, Ontario, Canada
🇨🇦CHUQ de recherché, Quebec City, Quebec, Canada
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath